SI1954718T1 - Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies - Google Patents

Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies

Info

Publication number
SI1954718T1
SI1954718T1 SI200631862T SI200631862T SI1954718T1 SI 1954718 T1 SI1954718 T1 SI 1954718T1 SI 200631862 T SI200631862 T SI 200631862T SI 200631862 T SI200631862 T SI 200631862T SI 1954718 T1 SI1954718 T1 SI 1954718T1
Authority
SI
Slovenia
Prior art keywords
antibodies
methods
antigen
vectors
compositions
Prior art date
Application number
SI200631862T
Other languages
Slovenian (sl)
Inventor
Stefan Barghorn
Ulrich Ebert
Heinz Hillen
Patrick Keller
Andreas Striebinger
Boris Labkovsky
Original Assignee
Abbvie Inc.
AbbVie Deutschland GmbH & Co. KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc., AbbVie Deutschland GmbH & Co. KG filed Critical Abbvie Inc.
Priority claimed from EP06818937.2A external-priority patent/EP1954718B1/en
Publication of SI1954718T1 publication Critical patent/SI1954718T1/en

Links

SI200631862T 2005-11-30 2006-11-30 Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies SI1954718T1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US74086605P 2005-11-30 2005-11-30
US77917106P 2006-03-03 2006-03-03
US78736106P 2006-03-30 2006-03-30
US84240006P 2006-09-05 2006-09-05
EP06818937.2A EP1954718B1 (en) 2005-11-30 2006-11-30 Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
PCT/EP2006/011530 WO2007062852A2 (en) 2005-11-30 2006-11-30 ANTI-Aβ GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES

Publications (1)

Publication Number Publication Date
SI1954718T1 true SI1954718T1 (en) 2015-01-30

Family

ID=50779222

Family Applications (3)

Application Number Title Priority Date Filing Date
SI200631887T SI2289909T1 (en) 2005-11-30 2006-11-30 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
SI200631768T SI1976877T1 (en) 2005-11-30 2006-11-30 Monoclonal antibodies against amyloid beta protein and uses thereof
SI200631862T SI1954718T1 (en) 2005-11-30 2006-11-30 Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SI200631887T SI2289909T1 (en) 2005-11-30 2006-11-30 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
SI200631768T SI1976877T1 (en) 2005-11-30 2006-11-30 Monoclonal antibodies against amyloid beta protein and uses thereof

Country Status (7)

Country Link
CN (2) CN105924521A (en)
CA (1) CA2918092C (en)
DK (1) DK2289909T3 (en)
ME (1) ME01826B (en)
NZ (1) NZ629387A (en)
SI (3) SI2289909T1 (en)
UA (1) UA95933C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7436449B2 (en) * 2018-07-17 2024-02-21 ジエンス ヘンルイ メデイシンカンパニー リミテッド Anti-Abeta antibodies, antigen-binding fragments thereof and their uses
CN109374902A (en) * 2018-10-08 2019-02-22 杭州康知生物科技有限公司 A kind of latex enhancing Immunoturbidimetric kit of quantitative detection IgG4 and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
MXPA00011348A (en) * 1998-05-21 2003-04-22 Univ Tennesse Res Corp Methods for amyloid removal using anti-amyloid antibodies.
UA81216C2 (en) * 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
DE10303974A1 (en) * 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use

Also Published As

Publication number Publication date
ME01826B (en) 2014-12-20
CN106008712A (en) 2016-10-12
SI2289909T1 (en) 2015-03-31
DK2289909T3 (en) 2015-02-02
CN105924521A (en) 2016-09-07
CA2918092A1 (en) 2007-06-07
UA95933C2 (en) 2011-09-26
CA2918092C (en) 2020-07-14
NZ629387A (en) 2016-01-29
SI1976877T1 (en) 2014-05-30

Similar Documents

Publication Publication Date Title
PL1954718T3 (en) Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
IL236427A (en) Isolated nucleic acids, vectors, host cells and methods of producing il-23p19 antibodies
HRP20181218T1 (en) Humanized anti-il-6 antibodies, compositions, methods and uses
HRP20190220T1 (en) Anti-il-23 antibodies, compositions, methods and uses
IL190472A (en) Anti-glypican-3 antibodies, methods of producing same and uses thereof
EP1910513A4 (en) Methods of isolating cells and generating monoclonal antibodies
IL197459A0 (en) Humanized proteins, including antibodies and methods for producing the same
IL202288A (en) Rsv-specific antibody or functional part thereof, nucleic acids encoding it, vectors, host cells, method for producing such antibody, compositions comprising the same and use thereof for treating rsv-related disorders
WO2008076560A3 (en) Human monoclonal antibodies to btla and methods of use
IL196478B (en) Humanized antibody and fragments thereof binding to amyloid beta and nucleic acids, vectors and cells for producing them, as well as pertinent therapeutic compositions, mixtures and uses thereof
WO2006119062A3 (en) Sclerostin epitopes
ZA200609573B (en) Griffithsin, Glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
SI1839120T1 (en) Anti-il-12 antibody based vectors, host cells, and methods of production and uses
SI1954718T1 (en) Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
WO2009086333A3 (en) Methods and compositions relatin to antibodies that bind a protein reticulon 3